These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2469509

  • 1. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
    Douay L.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():195. PubMed ID: 2469509
    [No Abstract] [Full Text] [Related]

  • 2. Purging by dye-mediated photosensitization.
    Porcellini A, Manna M, Marchetti-Rossi MT, Sparaventi G.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():188-9. PubMed ID: 2653501
    [No Abstract] [Full Text] [Related]

  • 3. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
    Gulati SC, Shank B, Sarris A, Berman E, Gee T, Cunningham I, Flomenberg N, O'Reilly RJ, Clarkson B.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485
    [No Abstract] [Full Text] [Related]

  • 4. Perspectives of monoclonal antibodies in the acute leukaemias.
    Hervé P, Wijdenes J, Racadot E.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological purging of bone marrow with reference to autografting.
    Santos GW, Colvin OM.
    Clin Haematol; 1986 Feb; 15(1):67-83. PubMed ID: 2421955
    [No Abstract] [Full Text] [Related]

  • 6. Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
    Rizzoli U, Mangoni L, Carella AM, Aglietta M, Porcellini A, Coleselli P, Angrilli F, Alessandrino EP, Madon E, Locatelli F.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():190-4. PubMed ID: 2653502
    [No Abstract] [Full Text] [Related]

  • 7. Mixed chimerism after allogeneic marrow transplantation.
    Frassoni F, Corvo R, Strada P, Sessarego M, Piaggio G, Figari O, Scarpati D, Bacigalupo A, Vitale V, Miceli S.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
    [No Abstract] [Full Text] [Related]

  • 8. High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?
    Dicke KA, Spinolo JA.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():184-6. PubMed ID: 2653500
    [Abstract] [Full Text] [Related]

  • 9. Purging multidrug resistant cells from bone marrow.
    Chao NJ, Aihara M, Kühl JS, Sikic BI, Blume KG.
    Prog Clin Biol Res; 1992 Jan; 377():13-23. PubMed ID: 1438409
    [No Abstract] [Full Text] [Related]

  • 10. Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
    Visani G, Rizzoli V, Dinota A, Aglietta M, Bernabei PA, Geraci L, Leoni P, Mangoni L, Meloni G, Motta MR.
    Haematologica; 1988 Jan; 73(3):179-81. PubMed ID: 2458996
    [No Abstract] [Full Text] [Related]

  • 11. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
    Santos GW.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological purging of bone marrow with drugs other than cyclophosphamide derivatives.
    Gorin NC.
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):437-46. PubMed ID: 2419956
    [No Abstract] [Full Text] [Related]

  • 13. [Minimal residual disease in leukemia and lymphoma: biological significance and clinical applications].
    Gavosto F, Saglìo G, Foà R.
    Haematologica; 1989 Oct; 74(5 Suppl):85-95. PubMed ID: 2512235
    [No Abstract] [Full Text] [Related]

  • 14. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
    Frondoza CG, Sinha S, Trivedi SM, Humphrey RL, Colvin OM.
    Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
    [Abstract] [Full Text] [Related]

  • 15. Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.
    Vallera DA.
    Cancer Treat Res; 1988 Jul; 37():515-35. PubMed ID: 2908642
    [No Abstract] [Full Text] [Related]

  • 16. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
    Ciobanu N, Paietta E, Andreeff M, Papenhausen P, Wiernik PH.
    Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
    [Abstract] [Full Text] [Related]

  • 17. Ablative therapy in bone marrow transplantation.
    Rybka WB.
    Bone Marrow Transplant; 1991 Aug; 7 Suppl 1():60. PubMed ID: 1675139
    [No Abstract] [Full Text] [Related]

  • 18. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
    Morishima Y.
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
    [Abstract] [Full Text] [Related]

  • 19. Etoposide in leukemia, lymphoma and bone marrow transplantation.
    Stadtmauer EA, Cassileth PA, Gale RP.
    Leuk Res; 1989 Nov; 13(8):639-50. PubMed ID: 2677526
    [Abstract] [Full Text] [Related]

  • 20. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M, Andersson BS, Wang Y, McCredie KB, Farquhar D.
    Cancer Res; 1988 Jan 15; 48(2):339-45. PubMed ID: 3275495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.